The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

Singapore-based Cognosphere mishandled data it collected on children who played the game by improperly sharing it with others, including advertisers, in violation of US law, the FTC alleged.

[Stay on top of transportation news: Get TTNews in your inbox.] The Federal Trade Commission sued PepsiCo on Jan. 17, alleging that it has engaged in illegal price discrimination by giving unfair ...

In response to the findings of FTC, UnitedHealth’s OptumRx defended its practices while claiming it has helped patients save money on medications, noted Fortune. Meanwhile, at the same time, CVS ...

The Federal Trade Commission (FTC) released a report finding that OptumRX, Express Scripts, and CVS Caremark Rx are engaged in widespread price gouging, according to Fortune. The investigation ...

OptumRX, under UnitedHealth’s ownership ... conversations about corporate accountability in health care. The FTC’s findings represent more than just corporate malpractice; they expose a ...